Status:
COMPLETED
Blood Flow Restriction Training in Chronic Heart Failure: an Effective Training Strategy?
Lead Sponsor:
University of Leeds
Conditions:
Chronic Heart Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this current study proposal is to identify the potential physiological adaptations arising from a combined BFR+HIIT training intervention in CHF patients. We hypothesise that the additi...
Detailed Description
Exercise training in CHF is a potentially effective intervention for improving symptomatic and prognostic outcomes, but remains underutilised in contemporary CHF management in the United Kingdom. This...
Eligibility Criteria
Inclusion
- Patients with New York Heart Association (NYHA) class II-III symptoms Stable CHF of at least 3 months duration On optimally tolerated medication for CHF No contraindications for cycling exercise Able and willing to give informed consent
Exclusion
- Class IV CHF Any contraindications to exercise Significant COPD (FEV1\<60%), severe renal disease (eGFR\<30), primary pulmonary hypertension as a co-morbidity Unable to give informed consent Current diagnosis of active cancer, inflammatory or musculoskeletal disease (e.g. rheumatoid arthritis), on-going infection or sepsis.
Key Trial Info
Start Date :
March 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03342833
Start Date
March 10 2018
End Date
April 1 2021
Last Update
April 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leeds Teaching Hospitals NHS Trust
Leeds, West Yorkshire, United Kingdom, LS16 5AR